Overview

Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Lu AA21004, once daily (QD), on cognitive dysfunction in patients with major depressive disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Duloxetine Hydrochloride
Vortioxetine